CombinedX (CX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Oct, 2025Executive summary
Revenue for Q3 2025 reached 200.0 MSEK, a 2.0% increase year-over-year, with organic growth at -2.5%.
EBITA improved to 17.2 MSEK from 10.6 MSEK, with EBITA margin rising to 8.6% from 5.4% year-over-year.
Profitability gains were driven by operational efficiency and successful mergers and acquisitions, notably Align and ERPkonsult.
Net income for Q3 was 4.0 MSEK, with EPS stable at 0.21 SEK.
For the nine months, revenue reached 674.0 MSEK (+0.3%), adjusted EBITA 62.4 MSEK (9.3% margin).
Financial highlights
Rolling 12-month revenue was 932.0 MSEK, with adjusted EBITA at 87.9 MSEK and margin at 9.4%.
Q3 EBITDA was 24.1 MSEK (12.1% margin), up from 19.2 MSEK (9.8%) last year.
Cash flow from operations in Q3 was -0.4 MSEK, down from 17.2 MSEK, mainly due to increased working capital tied to large deliveries.
Net debt/EBITDA at Q3 2025 was 1.0x, well below the target of 2.0x.
Equity ratio at quarter-end was 54.6%.
Outlook and guidance
Target to exceed IT consulting market growth organically and reach at least 1 billion SEK in revenue by 2025 through acquisitions.
Adjusted EBITA margin target is at least 12% on a rolling 12-month basis.
Market conditions remain cautious but stable, with ongoing demand for digitalization and AI services.
No formal guidance provided, but management expresses confidence in future prospects.
Latest events from CombinedX
- Record revenue, margin gains, and acquisitions drive a strategic shift to specialist brands.CX
Q4 202511 Feb 2026 - Strong revenue growth offset by sharply lower margins amid integration and market challenges.CX
Q2 202428 Jan 2026 - Revenue declined and margins improved, with acquisitions supporting strategic growth.CX
Q2 202517 Jul 2025 - Sales up 27.5% but margins and organic growth fell; restructuring targets improved 2025 results.CX
Q3 202413 Jun 2025 - Q1 2025 saw 6.5% revenue growth and resilient margins despite market challenges.CX
Q1 20256 Jun 2025 - Revenue surged but organic growth and margins fell; acquisitions set up 2025 recovery.CX
Q4 20245 Jun 2025